Medicine net August 16 124 medicine withdraw a bid!
▍ 69 pharmaceutical applications of withdrawal of hubei province
On August 15, hubei province's centralized purchasing service platform issued "the enterprise application to cancel the network information public display (20170815)". The application for the withdrawal of the target drug comes from the classified procurement system and the secondary trading system.
According to statistics, there are 69 products in total. Many of these are commonly used drugs, such as the infantile fever cough oral liquid, aspirin intestinal dissolving, heparin sodium injection, etc. Well-known pharmaceutical companies such as bayer, hengri and Chen xin are also among them. (see annex for details)
For the company's application for the bid withdrawal, hubei province's centralized procurement service platform has not disclosed the reasons for the application.
▍ rising raw material, production line modification, 55 drug withdrawal
But a few days ago, in Inner Mongolia autonomous region of Inner Mongolia autonomous region medicine purchasing network to cancel the qualification medicine notice, content is more abundant.
Inner Mongolia YaoXie procurement service center said: from January 1, 2017 to July 30, 2017, due to higher raw material, production line modification, such as environmental pollution causes many drugs to stop production, there are 27 pharmaceutical production enterprise (agent) to apply for disqualified from the net and ours.
There were 55 drugs involved. There are eight product regulations in the pharmaceutical industry in liaoning province. (see annex for details)
▍ products of withdrawal, no longer supply throughout the country
55 products have been removed! Not only was it withdrawn from Inner Mongolia, but it was no longer available throughout the country.
These drug firms from mark at the same time, submitted a unified national supply of commitment, commitment: "application for exit for the drug released in Inner Mongolia to exit the results, if there is supply in other provinces and cities, to accept the bad record list, accept according to the Inner Mongolia autonomous region YaoXie centralized purchasing record management method" processing ". According to the study, Inner Mongolia agreed to cancel the relevant Internet qualification of these products.
In this view, these drugs are at least ready to exit the national hospital market. Maybe it's the retail and clinic channels, and there's a possibility that there's a plan to stop production and not do it.
The attached:
